UK Variant Of Coronavirus May Be Harder To Diagnose With Many Current Tests: FDA
The agency is cautioning that current tests may give false negative results for patients with genetic mutations of SARS-CoV-2, making it harder to control the spread of the pandemic.
You may also be interested in...
The company is developing a vaccine with both adenoviral and mRNA technology that could potentially overcome resistance mutations on the SARS-CoV-2 spike protein.
Outgoing US FDA chief Stephen Hahn has signaled that he’ll seek a posting in public health, where he can increase equity and help in the fight against COVID-19.
If not used properly the test can mislead some patients that they do not have the coronavirus. The US FDA says health care providers should consider using another test if patients get a negative result.